Results 131 to 140 of about 1,829,544 (140)

[A case of hepatitis B surface antigen clearance achievement based on the combination of interferon and intermittent consolidation therapy]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Deng W, Wang SY, Wei X, Cao WH, Xie Y, Li MH.   +5 more
europepmc   +1 more source

[Advances in basic and experimental diagnostic research on liver diseases in 2025​]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Chen DB, Yang RF, Chen HS.
europepmc   +1 more source

[Histone deacetylases and alcohol-related liver disease]. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Yang Y, Yu M, Liu D, Tan Y.
europepmc   +1 more source

[Introduction of the key update points of the 2025 Canadian Association for the Study of the Liver guideline for the management of chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhuang H.
europepmc   +1 more source

[<i>Yiqi Jiedu</i> Formula regulates immune microenvironment of liver cancer in mice by inhibiting overactivation of NF-κB signaling pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wang Z, Liu L, Shi M, Hou Y, Dong L, Zhang G.   +5 more
europepmc   +1 more source

[A review of research progress in integrated traditional Chinese and Western Medicine for liver diseases]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhang Q, Tian B, Shan C, Cao ZH, Xu CJ, Hu ZJ, Qi XL.   +6 more
europepmc   +1 more source

[Research advances in nanobiotechnology targeting reactive oxygen species for radiation injury repair]. [PDF]

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
Guo C, Tang Q, Zhang J, Ran X, Huang Y, He Y.   +5 more
europepmc   +1 more source

[Analysis of liver histological characteristics and clinically related factors in patients with inactive HBsAg carriers]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zhang XY, Ren S, Zheng SJ, Fan RS, Ruan QF, Huang WQ, Gao HB, Xie Y, Li MH, Xue XL, Yang F, Fu JL, Chen XY.   +12 more
europepmc   +1 more source